Adverse events resulting from lasers used in urology.
OBJECTIVE
To collate world reports of adverse events (AEs) resulting from lasers used in urology.


METHODS
The Manufacturer and User Facility Device Experience (MAUDE) database of the United States Food and Drug Administration (FDA) was searched using the term "Laser for gastro-urology use." In addition, the Rockwell Laser Industries (RLI) Laser Accident Database was searched for the following types of lasers: neodymium-doped yttrium aluminum garnet (Nd:YAG), holmium:yttrium aluminum garnet (Ho:YAG), potassium titanyl phosphate (KTP), diode and thulium:YAG (Tm:YAG).


RESULTS
Both databases were last accessed on October 1, 2012. Overall, there were 433 AEs; 166 in MAUDE database (1992-2012) and 267 in RLI database (1964-2005). Most of the AEs (198/433 or 46%) resulted from generator failure or fiber tip breaking. Whereas there were 20 (4.6%) AEs harming medical operators, there were 159 (37%) AEs harming nonmedical operators using Nd:YAG, KTP, and diode lasers. Eye injuries ranging from mild corneal abrasions to total vision loss were reported in 164 AEs with the use of Nd:YAG, KTP, and diode lasers. Overall, there were 36 (8.3%) AEs resulting in patient harm, including 7 (1.6%) mortalities, 3 deaths from ureteral perforation using the Ho:YAG laser, and 4 deaths from air emboli using the Nd:YAG laser. Other reported patient injuries included bladder perforation resulting in urinary diversion in a patient, in addition to minor skin burns, internal burns, and bleeding in others. There were no AEs reported with the use of Tm:YAG laser.


CONCLUSIONS
Most of the AEs reported relate to equipment failure. There were no eye injuries reported with the use of Ho:YAG lasers. Caution must be exercised when using lasers in urology, including wearing appropriate eye protection when using Nd:YAG, KTP, and diode lasers.
Division of Urology, Department of Surgery, McGill University Health Center, McGill University, Montreal, Quebec, Canada.
Abdulaziz M
AM
Althunayan
Division of Urology, Department of Surgery, McGill University Health Center, McGill University, Montreal, Quebec, Canada; Department of Urology, Suez Canal University, Ismailia, Egypt
Mohamed A
MA
Elkoushy
Mostafa M
MM
Elhilali
Sero
S
Andonian
D000535:Aluminum / Q000009:adverse effects*; D005135:Eye Protective Devices; D006801:Humans; D053685:Laser Therapy / Q000009:adverse effects* / Q000295:instrumentation; D054023:Lasers, Semiconductor / Q000009:adverse effects*; D053844:Lasers, Solid-State / Q000009:adverse effects*; D011183:Postoperative Complications / Q000209:etiology*; D016896:Treatment Outcome; D014570:Urologic Diseases / Q000150:complications* / Q000601:surgery; D015019:Yttrium / Q000009:adverse effects*
C503779:yttrium-aluminum-garnet; D015019:Yttrium; D000535:Aluminum